Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

kyorin rimedio co.,ltd. - dihydrocodeine phosphate; dl-methylephedrine hydrochloride; chlorpheniramine maleate - dark brown syrup

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

kyorin rimedio co.,ltd. - dihydrocodeine phosphate; dl-methylephedrine hydrochloride; chlorpheniramine maleate - white tablet, diameter:9.0 mm, thickness:4.8 mm

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

viatris pharmaceuticals inc. - dihydrocodeine phosphate; dl-methylephedrine hydrochloride; chlorpheniramine maleate - pale brown syrup

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

viatris pharmaceuticals inc. - dihydrocodeine phosphate; dl-methylephedrine hydrochloride; chlorpheniramine maleate - white tablet with split line, diameter: approx. 9.0 mm, thickness: approx. 4.3 mm

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

teijin pharma limited - dihydrocodeine phosphate; dl-methylephedrine hydrochloride; chlorpheniramine maleate - chocolate-colored syrup

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

towa pharmaceutical co., ltd. - dihydrocodeine phosphate; dl-methylephedrine hydrochloride; chlorpheniramine maleate - pale brown syrup

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

viatris pharmaceuticals inc. - diprophylline; dihydrocodeine phosphate; dl-methylephedrine hydrochloride; diphenhydramine salicylate; acetaminophen; bromovalerylurea - white tablet, diameter: 9.7 mm, thickness: 4.4 mm

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - dihydrocodeine bitartrate (unii: 8lxs95bsa9) (dihydrocodeine - unii:n9i9hdb855), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e) - dihydrocodeine bitartrate 32 mg - acetaminophen, caffeine, and dihydrocodeine bitartrate tablets are indicated for the relief of moderate to moderately severe pain. this combination product is contraindicated in persons with hypersensitivity to dihydrocodeine, codeine, acetaminophen, caffeine, or any of the inactive components listed above, or any situation where opioids are contraindicated including significant respiratory depression (in unmonitored settings or in the absence of resuscitative equipment), acute or severe bronchial asthma or hypercapnia, and paralytic ileus. this combination product is subject to the provisions of the controlled substance act, and has been placed in schedule iii. dihydrocodeine can produce drug dependence of the codeine type and therefore has the potential of being abused. like other opioid analgesics, dihydrocodeine may produce subjective effects other than analgesia (e.g., euphoria, relaxation), which may contribute to abuse by some patients. psychological dependence, physical dependence, and tolerance may d

Malta - English - Medicines Authority

wockhardt uk limited - dihydrocodeine tartrate - tablet - dihydrocodeine tartrate 30 mg - analgesics

Malta - English - Medicines Authority

pinewood laboratories limited ballymacarbry, clonmel, co. tipperary, ireland - dihydrocodeine tartrate - tablet - dihydrocodeine tartrate 30 mg - analgesics